StockNews.com Initiates Coverage on Marinus Pharmaceuticals (NASDAQ:MRNS)
StockNews.com assumed coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) in a note issued to investors on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Marinus Pharmaceuticals Price Performance MRNS opened at $0.55 on Friday. The stock has a market capitalization of $30.32 million, a PE ratio of […]
StockNews.com assumed coverage on shares of Marinus Pharmaceuticals (NASDAQ:MRNS – Get Free Report) in a note issued to investors on Saturday. The firm set a “sell” rating on the biopharmaceutical company’s stock. Marinus Pharmaceuticals Price Performance MRNS opened at $0.55 on Friday. The stock has a market capitalization of $30.32 million, a PE ratio of […]
